Coston McIsaac & Partners’s Labcorp LH Stock Holding History

Coston McIsaac & Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	28	–	–	﹤0.01%	641
2026 Q1	$7K	Hold	28	–	–	﹤0.01%	633
2025 Q4	$7K	Hold	28	–	–	﹤0.01%	621
2025 Q3	$8K	Hold	28	–	–	﹤0.01%	576
2025 Q2	$7K	Hold	28	–	–	﹤0.01%	573
2025 Q1	$6K	Hold	28	–	–	﹤0.01%	569
2024 Q4	$6K	Hold	28	–	–	﹤0.01%	565
2024 Q3	$6K	Hold	28	–	–	﹤0.01%	574
2024 Q2	$5K	Hold	28	–	–	﹤0.01%	565
2024 Q1	$6K	Hold	28	–	–	﹤0.01%	550
2023 Q4	$6K	Hold	28	–	–	﹤0.01%	546
2023 Q3	$5K	Sell	28 -5	-15%	-$1.05K	﹤0.01%	560
2023 Q2	$6K	Hold	33	–	–	﹤0.01%	573
2023 Q1	$6K	Hold	33	–	–	﹤0.01%	566
2022 Q4	$6K	Hold	33	–	–	﹤0.01%	565
2022 Q3	$5K	Hold	33	–	–	﹤0.01%	510
2022 Q2	$7K	Buy	+33	New	+$7.03K	﹤0.01%	314

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Coston McIsaac & Partners's LH Position: Q2 2026 in Review

Coston McIsaac & Partners held its Labcorp (LH) position steady in Q2 2026 at 28 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #641.

Coston McIsaac & Partners first reported a position in LH in Q2 2022 and has held it in 17 quarters since. The position peaked at $8K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Coston McIsaac & Partners held 28 shares of Labcorp worth $7K as of Q2 2026.
Coston McIsaac & Partners left its Labcorp share count unchanged in Q2 2026.
Labcorp made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #641 holding.
Coston McIsaac & Partners first reported a position in Labcorp in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's Labcorp position peaked at $8K in Q3 2025.
1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.